Tag: "described" at medical news

Cancer Protection Compound Abundant In Broccoli Sprouts

...f sulforaphane's chemoprotective properties. Work described in thestudy is thesubject of issued and pending patents. A systematic search for dietary sources of compounds that increaseresistance tocancer-causing agents led the Hopkins group to focus on naturally occurringcompounds inedible plants that m...

NIH Honors Emory Researcher With Merit Award For Work On Renin-Angiotensin System

...d." In a 1994 article in Nature, Bernstein described the unique messagingpathway used by the AT1 receptor to send messages from the cell surface to thecell nucleus. In response to angiotensin II, the AT1 receptor activates anintracellular messenger called the Jak2 kinase, which in turn initiates acas...

Declining National Rates Of HIV-Related Deaths And Illnesses Due To Combination Antiretroviral Therapy With Protease Inhibitors

...V-infected patients. The nationwide study described in the article found that the numberHIV-related deaths decreased from almost 30 per 100 person-years in 1994 toabout 9 per 100 person-years by mid-1997. At around the same time, prescriptionrates of combination antiretroviral therapy increased from 2...

BioNumerik Reports Preclinical Antitumor Data On Two Novel Supercomputer Engineered Anticancer Agents At 89th Annual AACR Conference

...red to water solublecamptothecins. Camptothecins, described as Topoisomerase I inhibitors, represent some of themost active anticancer drugs in existence. Due to formulation problems,however, the great majority of camptothecins in development or on the markethave been made water soluble to allow easier drug ...

Anti-Clotting Drug May Cause Potentially Fatal Platelet Disorder

...re generally unaware of this side effect, which is described as"having a rare association" in the package insert produced by the pharmaceuticalmanufacturer, Hoffmann-LaRoche of Basel, Switzerland. Ticlopidine's toxicity has raised concern since its approval by the Foodand Drug Administration. Early cli...

Most People Cant Identify Stroke Symptoms

... sudden severe headache with no known cause (often described as the worst headache in a person's life). The investigators found that only 57 percent of the study participants correctly listed at least one of these five symptoms or warning signs, 28 percent correctly listed two or more, and 8 percent correctly...

ONYX Pharmaceuticals Reports Phase II Clinical Trial Results At ASCO Meeting

...ecompany's expectations.In addition to the matters described in this pressrelease, the timeline for clinical activity, results of pending or futureclinical trials, including the trials of ONYX-015, and changes in the status ofthe company's collaborative relationships, as well as the riskfactors listed from tim...

New Elementary School Program Lowers Cardiovascular Risks In Children

...(NINR), NIH. The findings from the CHIC study are described in the August 3 issue of PEDIATRICS. This is the first study to test the program on children with at least two CVD risk factors and to compare the effectiveness of a classroom-wide program with a program providing more individualized interventions. T...

'DES Daughters' Had Increased Rates of Cancer; An Animal Study Shows 'DES Granddaughters' May Too

...s in male mouse siblings in which like thefemales described in this study, reproduction is not affected but rare cancersare observed. A report on the effects in males is being completed, Newboldsaid. Newbold and her colleagues said that although additional study of risksfrom environmental agents ar...

Electronic Nose Inspects Cheese, Hints At Human Sense Of Smell

... cheeses. It noted that the cheese which panelists described as especially sharp smelled... different from the onethey described as especially bland. The device also agreedwith the human panelists that the ...

UNC-CH Studies Show Medicine Can Reverse Osteoporosis From Transplants, Cystic Fibrosis

... in cystic fibrosis patients. The studies, described at the 12th Annual North American Cystic FibrosisConference in Montreal that ended Sunday (Oct. 18), found that patients treatedwith Pamidronate experienced about a 10 percent reversal of bone loss caused byimmuno-suppressant drugs. Drs. Robe...

Duke Physicians: Clinicians Have Ethical Obligation To Consider Alternative Medicine

...ericanMedical Association. In the article, described as a "policy perspective," Drs. JeremySugarman and Larry Burk tackle the question of the traditional clinician's rolein a patient's use of alternative medical treatment. The issue focuses onalternative medicine. "We have taken a hard look ...

Maxim Phase II Clinical Trial Highlights Substantial Increase In Leukemia-FreeSurvival For Acute Myelogenous Leukemia Patients

...r immunotherapies. Complementing the AML results described above, Phase II clinical studies ofMaxamine Therapy in advanced malignant melanoma have shown a more than doublingin survival outcomes and the maintenance of patient quality of life duringtreatment. Earlier-stage clinical studies have also suggested...

Nerve Agent Sensor A Million Times More Sensitive

...the arsenals of some countries. The sensor is described in the January 15 print edition of the peerreviewed journal Analytical Chemistry, published by the American ChemicalSociety, the world's largest scientific society. The web edition of the articlewaspublished Dec. 10. The sensor, which combines ...

Fred Hutchinson Cancer Research Center And Targeted Genetics Corp. Publish Data On Adoptive Immunotherapy For HIV

...broad potential to make adoptive immunotherapy, as described inthis paper, a clinical reality. FHCRC was issue.... The REM technology overcomes this hurdleand, as described in the publication, rapidly expands antigen-specific cells tonumbers greater than one billion, which...

New Surgery At Cedars-Sinai Provides Hope For Epilepsy Patient Who Has Had A Lifetime Of Seizures

... years. "I typically would just stare into space," described Mary Kate, adding that shesometimes blacked out or would remain aware but unable to speak. "I've beenfortunate -- I didn't fall down on the floor or tear my clothes off oranything." But there have been some close calls and frightening moments. Whent...

Immunex's TRAIL Molecule Shows Potential As Anti-Tumor Agent

...mors, by adirect and specific mechanism. The work described in the journal was conductedin mice by scientists ...provals, product commercialization and other risks described fromtime to time in the SEC reports filed by Immunex, including the most recentlyfiled Form 10K and ...

Far Few Drugs Are Tested On Children

... atthe Children's Hospital in Birmingham, Alabama, described 30 years ago as"pharmaceutical orphans"....

Promising Bone Cancer Therapy Advances To Next Level

...nnual scientificmeeting in Hawaii. He also described the current nationwide clinical trial, designed totest the compound's potency in giving pain relief to patients whose cancer hasspread to the bone. Diatide Inc., a New Hampshire biotechnology company that has licensedthe technology from BNL...

UW-Madison Center One Of Two Sites Nationwide Selected For Clinical Trial Of Cancer Drug

...e attentionafter a May 1998 New York Times article described early results in mice in thelaboratory of Dr. Judah Folkman of Harvard Medical School. In May 1998, the NCIcalled animal studies on the compound "encouraging" and later announced it wouldentertain applications from research organizations to conduct t...

1 2 3 4 5 6 7 8 9 10

(Date:7/22/2014)... Bayonne, NJ (PRWEB) July 22, 2014 CarePoint ... been recently elected as the President of the medical staff ... Dr. Levine will serve as President, as voted on by ... interests of the medical staff in relation to the administration ... the needs of physicians and to work to make the ...
(Date:7/22/2014)... 5i Sciences, a medical technology company ... Molly Coye, M.D., M.P.H. to a role as Senior ... on the market introduction of innovative technologies that impact ... advise on strategies for building a successful commercial healthcare ... Dr. Coye is currently the Chief Innovation Officer of ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 According to ... Health care, Automobile, Aerospace & Defense, Marine and Mining) ... Middle East, and Rest of the world) - Forecast ... is expected to grow at a CAGR 8.00% to ... Europe is estimated to grow at a CAGR of ...
(Date:7/22/2014)... The Latin America Drilling fluid and Completion fluid ... fluid market in Latin America with analysis and forecast of ... America is estimated to grow from around $0.93 billion in ... 9.2%, for the given period. , Browse through the TOC ... Report, to get an idea of the in-depth analysis provided. ...
(Date:7/22/2014)... The donation from the Edusei Foundation was greatly appreciated by ... of strategic engineering, such assistance tends to etch good memories ... It provided a sense of family to them, which the ... Foundation donated various amounts of; milk, soap, frytol, sugar, ... Government of Ghana established the Kumasi Children’s Home in 1965 ...
Breaking Medicine News(10 mins):Health News:Dr. Howard Levine Elected President of the Medical Staff at Bayonne Medical Center 2Health News:5i Sciences Announces Appointment of a Senior Healthcare Consultant and Successful Financing 2Health News:Global Actuators Market Estimated to Reach $59.32 Billion by 2019 – New Report by MarketsandMarkets 2Health News:Global Actuators Market Estimated to Reach $59.32 Billion by 2019 – New Report by MarketsandMarkets 3Health News:Global Actuators Market Estimated to Reach $59.32 Billion by 2019 – New Report by MarketsandMarkets 4Health News:Latin America Drilling Fluid & Completion Fluid Market is Expected to Reach $1.45 Billion in 2018 - New Report by MicroMarket Monitor 2Health News:Latin America Drilling Fluid & Completion Fluid Market is Expected to Reach $1.45 Billion in 2018 - New Report by MicroMarket Monitor 3Health News:Latin America Drilling Fluid & Completion Fluid Market is Expected to Reach $1.45 Billion in 2018 - New Report by MicroMarket Monitor 4Health News:Latin America Drilling Fluid & Completion Fluid Market is Expected to Reach $1.45 Billion in 2018 - New Report by MicroMarket Monitor 5Health News:Latin America Drilling Fluid & Completion Fluid Market is Expected to Reach $1.45 Billion in 2018 - New Report by MicroMarket Monitor 6Health News:Edusei Foundation Donates Food and Needed Items to Kumasi Children’s Home in Ashanti Region of Ghana 2
Other Tags
workershospitalityriskdoesnbarcodestudentshappensmutatetapelescolcathetersconsiderablythrivecommissionereschenbachvon